Literature DB >> 11156541

Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

J S Axford1, F A Howe, C Heron, J R Griffiths.   

Abstract

OBJECTIVE: To quantify N-acetylaspartate (NAA), total creatines (tCr), total cholines (tCho), and myo-inositol (mI) levels in normal and abnormal appearing white matter of patients with neuropsychiatric systemic lupus erythematosus (NPSLE) in order to determine the specific changes in metabolite concentrations.
METHODS: Axial proton density and T(2) weighted magnetic resonance images, and short echo time (TE 30 ms) (1)H spectra were acquired with a GE SIGNA 1.5 T magnetic resonance system. Concentrations of NAA, tCr, tCho, and mI were determined, using brain tissue water as a reference, from nine patients (seven female, mean age 40.3 years, range 16-65) with NPSLE and eight healthy women (mean age 43 years, range 31-65).
RESULTS: A significant rise of tCho (12.4%, p<0.05) and mI (31.4%, p<0.005) and a significant reduction in NAA (-12%, p<0.05) was found in normal appearing white matter compared with controls. Analysis according to severity of the clinical NPSLE features (subgrouped as major or minor) showed that SLE major had reduced NAA compared with SLE minor (-18.4%, p<0.05) and controls (-20%, p<0.005). The SLE major group showed a significant rise of mI (32%, p<0.01) and the SLE minor group a significant increase in tCho (18.6%, p<0.05) compared with controls. Longitudinal analysis of brain metabolites in normal appearing white matter showed consistent abnormalities in NAA, tCho, and mI in a patient with stable clinical features and a constant rise of tCho, but transient rise of mI was seen during a flare of disease in another patient.
CONCLUSION: Quantitative (1)H magnetic resonance spectroscopy (MRS) suggests a particular course of neurometabolite changes that precedes irreversible reductions in NAA and permanent neuronal loss. Initially, in patients with SLE minor, there is a significant rise in tCho and a trend (reversible) for mI also to be raised. In patients with SLE major the NAA is significantly and permanently reduced and mI is significantly raised, whereas the tCho levels are near normal. Further investigations are needed to determine how specific MRS is as a clinical marker for brain disturbance in SLE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156541      PMCID: PMC1753471          DOI: 10.1136/ard.60.2.106

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  42 in total

1.  Automated single-voxel proton MRS: technical development and multisite verification.

Authors:  P G Webb; N Sailasuta; S J Kohler; T Raidy; R A Moats; R E Hurd
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

Review 2.  Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium.

Authors:  H M Belmont; S B Abramson; J T Lie
Journal:  Arthritis Rheum       Date:  1996-01

3.  Brief report: organic osmolytes in the brain of an infant with hypernatremia.

Authors:  J H Lee; E Arcinue; B D Ross
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

4.  Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.

Authors:  W L Sibbitt; L J Haseler; R H Griffey; B L Hart; R R Sibbitt; N A Matwiyoff
Journal:  AJNR Am J Neuroradiol       Date:  1994-05       Impact factor: 3.825

5.  Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.

Authors:  R Kreis; T Ernst; B D Ross
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

6.  Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.

Authors:  D Häussinger; J Laubenberger; S vom Dahl; T Ernst; S Bayer; M Langer; W Gerok; J Hennig
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

7.  Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease.

Authors:  S D Denburg; S A Behmann; R M Carbotte; J A Denburg
Journal:  Arthritis Rheum       Date:  1994-03

8.  Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus.

Authors:  M J Jarek; S G West; M R Baker; K M Rak
Journal:  Arthritis Rheum       Date:  1994-11

9.  Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus.

Authors:  M M Stimmler; P M Coletti; F P Quismorio
Journal:  Semin Arthritis Rheum       Date:  1993-04       Impact factor: 5.532

10.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Authors:  J S Videen; T Michaelis; P Pinto; B D Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  17 in total

1.  Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study.

Authors:  Patricia Cagnoli; Richard E Harris; Dan Frechtling; George Berkis; Richard H Gracley; Courtney C Graft; Suzan E Lowe; Thomas L Chenevert; William J McCune; Stephen Gebarski; Pia C Sundgren
Journal:  Acad Radiol       Date:  2013-10       Impact factor: 3.173

2.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

3.  Proton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.

Authors:  Jeffrey R Yager; Vincent A Magnotta; James A Mills; Stacie M Vik; Michelle T Weckmann; Aristides A Capizzano; Roger Gingrich; Leigh J Beglinger
Journal:  Psychiatry Res       Date:  2011-01-11       Impact factor: 3.222

4.  MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus.

Authors:  P C Sundgren; J Jennings; J T Attwood; B Nan; S Gebarski; W J McCune; Y Pang; P Maly
Journal:  Neuroradiology       Date:  2005-07-09       Impact factor: 2.804

5.  Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging.

Authors:  Caterina Rosano; Anna L Marsland; Peter J Gianaros
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

6.  Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.

Authors:  Ece Ercan; Cesar Magro-Checa; Romain Valabregue; Francesca Branzoli; Emily T Wood; Gerda M Steup-Beekman; Andrew G Webb; Tom W J Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Brain       Date:  2016-03-11       Impact factor: 13.501

7.  Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity.

Authors:  M Petrou; R E Harris; B R Foerster; S A McLean; A Sen; D J Clauw; P C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

Review 8.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 9.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

Review 10.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.